Veracyte Inc (FRA:12V)
€ 39.4 0.8 (2.07%) Market Cap: 3.16 Bil Enterprise Value: 2.92 Bil PE Ratio: 0 PB Ratio: 2.76 GF Score: 81/100

Veracyte Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 03, 2020 / 07:30PM GMT
Release Date Price: €23.4 (+0.86%)
Brandon Couillard
Jefferies LLC, Research Division - Equity Analyst

Thanks. Good afternoon, everybody. Welcome to the Jefferies 2020 Virtual Global Healthcare Conference. I'm Brandon Couillard. I cover the life science tools and diagnostics sector here at the firm.

Very happy to have Veracyte with us back at the conference this year. And here to share an update on the new things going on with the company, Chairman and CEO, Ms. Bonnie Anderson. Bonnie?

Bonnie H. Anderson
Veracyte, Inc. - Co-Founder, Chairman & CEO

Thank you, Brandon. I'd like to start by thanking Jefferies for the opportunity to be here at this virtual healthcare conference today and of course, remind everyone of the safe harbor statement that we all have to be aware of.

Veracyte is a global genomic diagnostic company, and we are transforming care throughout the patient journey. I'm excited to give you an update today about all the great things we have going on. It seems like just yesterday, back in 2008, just 12 years ago, that we founded the company with a mission to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot